HANNAH'S HOPE FOR GIANT AXONAL NEUROPATHY INC (EIN 450593226) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2008

Legal Domicile

Principal Officer

ALLISON T MOORE

Phone

5182755359

Tax Period

2024-01-01 to 2024-12-31

HANNAH'S HOPE FOR GIANT AXONAL NEUROPATHY INC, founded in 2008, is a small nonprofit in the Medical Research sector that reported $198K in total revenue in fiscal year 2024. Revenue surged 104% from the prior year, signaling strong growth momentum. Expenses of $538K exceeded revenue, resulting in a 171% operating deficit.

Mission

DEDICATED TO FUNDING RESEARCH FOR A TREATMENT AND/OR A CURE FOR GIANT AXONAL NEUROPATHY

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $12,283

Program Service Revenue $0

Investment Income $186,122

Other Revenue $0

TOTAL REVENUE $198,405

Expense Breakdown

Grants Paid $232,248

Salaries & Benefits $223,424

Fundraising Expenses $0

Program Expenses $470,784

Other Expenses $82,782

TOTAL EXPENSES $538,454

Year-over-Year Comparison

	2024	2023	Change
Revenue	$198,405	$97,225	+1.0%
Expenses	$538,454	$6,029,768	-0.9%
Net Income	$-340,049	$-5,932,543	-0.9%

Key Indicators

✓ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

$210,279

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
ALLISON T MOORE	PRESIDENT	N/A	Officer Director	$0	$0	$0
KATIE HOGAN	SECRETARY	N/A	Officer Director	$0	$0	$0
KATHY BUCKLEY	TREASURER	N/A	Officer Director	$0	$0	$0
JOSEPH GERARD HACIA PHD	DIRECTOR	N/A	Director	$0	$0	$0
CHRISTA GAGNON	DIRECTOR	N/A	Director	$0	$0	$0
AMBER N FREED	DIRECTOR	N/A	Director	$0	$0	$0
LORI SAMES	EXECUTIVE DI	N/A	Key Emp	$190,500	$19,779	$210,279

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	$198,405	$538,454	$2,879,947	$-340,049
2023	$97,225	$6,029,768	$4,672,730	$-5,932,543
2022	$-717,738	$620,035	$8,206,230	$-1,337,773
2021	$6,718,842	$368,597	$9,892,144	$6,350,245
2020	$2,147,919	$848,319	$3,509,536	$1,299,600
2019	$170,920	$437,301	$2,205,057	$-266,381
2018	$1,227,266	$468,257	$2,483,866	$759,009

HANNAH'S HOPE FOR GIANT AXONAL NEUROPATHY INC